Dianthus Therapeutics (DNTH) Net Cash Flow (QoQ) (2017 - 2025)
Dianthus Therapeutics (DNTH) Net Cash Flow (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,267.61% |
| Jun 30, 2025 | 124.62% |
| Mar 31, 2025 | -16.52% |
| Dec 31, 2024 | 96.12% |
| Sep 30, 2024 | -1,702.22% |
| Jun 30, 2024 | -107.88% |
| Mar 31, 2024 | 890.99% |
| Dec 31, 2023 | -121.34% |
| Sep 30, 2023 | 582.55% |
| Jun 30, 2023 | 118.34% |
| Mar 31, 2023 | 136.47% |
| Dec 31, 2022 | -120.27% |
| Sep 30, 2022 | 726.71% |
| Jun 30, 2022 | 71.72% |
| Mar 31, 2022 | -131.31% |
| Dec 31, 2021 | -1,133.49% |
| Sep 30, 2021 | -97.63% |
| Jun 30, 2021 | 1,293.11% |
| Mar 31, 2021 | 89.39% |
| Dec 31, 2020 | -1,648.82% |